SCHEDULE: Deerfield Entities Report 4.34% Stake in CalciMedica

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn jointly reported beneficial ownership of 4.34% of CalciMedica Inc.'s common stock, primarily through warrants.

Summary

• Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an Amendment No. 1 to Schedule 13G for CalciMedica Inc.
• The reporting persons collectively beneficially own 653,253 shares of CalciMedica Inc. Common Stock.
• This aggregate amount represents 4.34% of the class of CalciMedica Inc. Common Stock.
• The shares are primarily comprised of Common Stock issuable upon the exercise of warrants held by Deerfield Partners, L.P.
• All reporting persons share voting and dispositive power over the 653,253 shares.
• The filing indicates that the securities were not acquired and are not held for the purpose of changing or influencing control of CalciMedica Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a standard beneficial ownership report (Schedule 13G) indicating a passive stake below 5% and does not contain operational or financial news.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding CalciMedica Inc.'s future operations or financial performance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by passive investors who own more than 5% of a company's stock, or amendments to such holdings. This filing indicates a passive stake below the 5% threshold, suggesting a non-activist investment approach by the Deerfield entities in CalciMedica Inc.

Key Dates

Keywords

CalciMedica Inc., Deerfield Mgmt, Deerfield Management Company, Deerfield Partners, James E. Flynn, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Ownership